Company Information

VIVO BIO TECH LTD.

NSE : NABSE : 511509ISIN CODE : INE380K01017Industry : Pharmaceuticals & DrugsHouse : Private
BSE45.060.06 (+0.13 %)
PREV CLOSE ( ) 45.00
OPEN PRICE ( ) 46.07
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 12591
TODAY'S LOW / HIGH ( )45.00 46.50
52 WK LOW / HIGH ( ) 21.0556
NSE
This Company is not listed in NSE
Company SecretaryVaishnavi Kiran Ayinampudi
Non Executive DirectorShivanand Nayak Karopadi
Non Executive Independent DirectorKunda Kalpana
Shyam Sunder Tipparaju
Whole Time DirectorM Kalyan Ram
Alangudi Sankaranarayanan
Kalyan Kompella
Incorporation Year : 12-02 1987

Registered Office :

Address : 3rd Floor, Ilyas Mohammed Khan Estate,8-2-672 / 5 & 6, Road No.1,Banjara Hills Hyderabad,
Telangana-500034 .

Phone :

Email :  investors@vivobio.com 

Industry : Pharmaceuticals & Drugs

Listing : BSE

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.